Tolerance of regular meal intake with mycoprotei

Completed

• Conditions: overige gezondheids parameters; intestinal discomfort and general health; 10017947

• Registration Number: NL-OMON50091
• Lead Sponsor: Bioscienz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 24

Inclusion Criteria

Apparently healthy men and women
Age between 18 and 70 years
Body mass index (BMI) between 18.5 and 29.9 kg/m2

Exclusion Criteria

* Any metabolic, gastrointestinal, inflammatory or chronic disease (such as
diabetes, anaemia, hepatitis, cardiovascular disease)
* History of gastro-intestinal surgery or having (serious) gastro-intestinal
complaints
* History of liver dysfunction (cirrhosis, hepatitis)
* Kidney dysfunction (self-reported)
* Use of medication that may influence the study results, such as gastric acid
inhibitors or laxatives
* Reported slimming or medically prescribed diet
* Current smokers
* Alcohol intake *4 glasses of alcoholic beverages per day
* Pregnant, lactating or wishing to become pregnant in the period of the study
(self-reported)
* Abuse of illicit drugs
* Having food allergies
* Participation in another clinical trial at the same time
* Being an employee of the department Consumer Science & Health group of
Wageningen Food & Biobased Research

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primairy study parameter is frequency and severity of gastro-intestinal<br /><br>complaints. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are health parameters derived from blood samples taken<br /><br>before and after the intervention.Additional samples (including stool samples)<br /><br>will be collected to enable future measurements when requested by the<br /><br>assessment committee of the novel food dossier</p><br>